# EUCRATES BIOMEDICAL ACQU COR (EUCR)

> Institutional ownership reported to the SEC as of Q1 2023, from Form 13F filings. Source: https://holderbook.com/stocks/EUCR/

- Reporting holders: 4
- Reported value: $3.0M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [EcoR1 Capital, LLC](https://holderbook.com/funds/1587114-ecor1-capital-llc/) | $2.0M | 200,000 | 0.1% | 9 |
| [SkyView Investment Advisors, LLC](https://holderbook.com/funds/1848237-skyview-investment-advisors-llc/) | $728.0K | 71,773 | 0.2% | 7 |
| [DEUTSCHE BANK AG\](https://holderbook.com/funds/948046-deutsche-bank-ag/) | $222.3K | 21,923 | 0.0% | 2 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $7.0K | 647 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2023 | 4 | $3.0M |
| Q4 2022 | 5 | $3.0M |
| Q3 2022 | 37 | $84.5M |
| Q2 2022 | 37 | $76.7M |
| Q1 2022 | 39 | $73.2M |
| Q4 2021 | 39 | $64.6M |
| Q3 2021 | 34 | $50.1M |
| Q2 2021 | 31 | $47.9M |
| Q1 2021 | 20 | $41.8M |
| Q4 2020 | 5 | $13.9M |